The EPS projection of TearLab Corporation (NASDAQ:TEAR) for quarter ended 2016-09-30 is $-0.07. A week before, the EPS forecast was $-0.07 against target of $-0.07, a month earlier. This estimate stood at $-0.07 60 days earlier versus forecast of $-0.07 90 days earlier, confirming a deviation of 0%.
TearLab Corporation (NASDAQ:TEAR) reported that 18 days ago, the positive EPS revisions were 2 and negative revisions at 0.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 2, 3, 0 and 3, respectively.
The downgrade of EPS estimates for TearLab Corporation (NASDAQ:TEAR) in the preceding 120, 60, 30 and 90 days were 0, 0, 0 and 0, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of TearLab Corporation (NASDAQ:TEAR) was $-0.07. This projection was computed after accounting 3 calls. As reported on 2016-05-04 the EPS was $-0.21. The change was $0.02, demonstrating a percentage deviation of 8.7%. The projections confirmed a standard deviation of 0.02.
Quarterly Sales Estimates
For the fiscal 2016, the yearly sales target for TearLab Corporation (NASDAQ:TEAR) stands at $8.013 and the median estimate at $8.1. Almost 3 analysts announced their estimates.
The highest estimate is $8.1 while the lowest target is $7.84 showing standard deviation of 0.15%.
As many as 3 analysts released sales estimates reised in upside while 3 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 3 revised sales number projection on upside while 3 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 3 hiked sales estimations and 3 reduced sales forecast. TearLab Corporation (NASDAQ:TEAR) stated that the change in forecast was 0%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...